SFC
ABBV icon

Strategic Financial Concepts’s AbbVie ABBV Stock Holding History

Strategic Financial Concepts’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,161
Closed -$252K – 240
2026
Q1 		$252K Buy
+1,161
New +$258K 0.06% 242
2025
Q2 		– Sell
-2,128
Closed -$446K – 281
2025
Q1 		$446K Sell
2,128
-201
-9% -$39.1K 0.08% 193
2024
Q4 		$414K Buy
2,329
+845
+57% +$155K 0.08% 202
2024
Q3 		$293K Sell
1,484
-278,047
-99% -$51.9M 0.09% 174
2024
Q2 		$145K Buy
279,531
+276,946
+10,714% +$45.9M 0.08% 148
2024
Q1 		$471K Buy
2,585
+615
+31% +$106K 0.11% 171
2023
Q4 		$305K Sell
1,970
-1,343
-41% -$196K 0.18% 101
2023
Q3 		$494K Buy
3,313
+213
+7% +$31.3K 0.17% 138
2023
Q2 		$418K Sell
3,100
-26
-0.8% -$3.81K 0.15% 144
2023
Q1 		$498K Buy
+3,126
New +$478K 0.2% 113

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Strategic Financial Concepts's ABBV Position: Q2 2026 in Review

Strategic Financial Concepts sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,161 shares — an estimated $252K sold.

Strategic Financial Concepts first reported a position in ABBV in Q1 2023 and held it in 10 quarters. The position peaked at $498K in Q1 2023. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Strategic Financial Concepts reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Strategic Financial Concepts sold 1,161 AbbVie shares in Q2 2026, an estimated $252K.
  • Strategic Financial Concepts first reported a position in AbbVie in Q1 2023 and held it in 10 quarters.
  • Strategic Financial Concepts's AbbVie position peaked at $498K in Q1 2023.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strategic Financial Concepts's 13F filing for Q2 2026, filed 28 Jul 2026.